This annual meeting is sponsored by the American College of Rheumatology for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical conditions being discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other healthcare professionals at arriving at their own conclusions and consequent application. Attendees participating in this medical education program do so with full knowledge that they waive any claim they may have against the College for reliance on any information presented during these educational activities. The College does not guarantee, warrant or endorse any commercial products or services.

The ACR's CME purpose is to provide comprehensive education to improve the knowledge and performance of physicians, scientists and other health professionals. The ACR will offer evidence-based educational activities designed to enhance practice performance and improve the quality of care in those with or at risk for arthritis and rheumatic and musculoskeletal diseases.

At the conclusion of the 2013 annual meeting, attendees should be able to:

• identify recent developments in the diagnosis and management of patients with rheumatic diseases
• outline new technologies for the treatment of rheumatologic problems
• describe potential challenges in the delivery of care to patients with rheumatic diseases and to specify possible solutions
• utilize new research data to improve the quality of care of patients with rheumatic diseases
• summarize recent rheumatology research findings

The program is the result of a planning process that identified educational needs to change or enhance the knowledge, competence or performance of rheumatology professionals. The program's content was derived from both needs assessment and practice gap analysis that took professional activities, practice setting, ABIM recertification requirements and physician attributes into account.

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

International Physicians: International physicians, who register as part of a group and require AMA PRA Category 1 Credit(s)™, must provide the following information to your tour leader: full name, mailing address, telephone and fax numbers, and e-mail address. The information will be used to verify your meeting attendance.

Health Professionals: Certificates of participation will be available to attendees participating in an activity designated for AMA PRA Category 1 Credit™.

For non-CME sessions, attendees may also request a certificate of participation.

It is the policy of the American College of Rheumatology to ensure that its CME activities are independent and free of commercial bias. To ensure content objectivity and balance, and guarantee that the content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control content disclose all relevant relationships with any commercial interest if the relationship is financial and occurred within the past 12 months. If there are relationships that create a conflict of interest, these must be resolved in accordance with the ACR's CME Resolution of Conflict policy prior to the participation of the individual in the development or presentation of CME content. Disclosure information will be available in August in My Annual Meeting.

This annual meeting is sponsored by the American College of Rheumatology for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical conditions being discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other healthcare professionals at arriving at their own conclusions and consequent application. Attendees participating in this medical education program do so with full knowledge that they waive any claim they may have against the College for reliance on any information presented during these educational activities. The College does not guarantee, warrant or endorse any commercial products or services.

The annual meeting is a private event. Programs presented at the meeting are for the education of attendees and purchasers of recorded presentations as authorized by the American College of Rheumatology. Information displayed or presented at all sessions during the annual meeting is the property of the ACR or the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced or distributed without the written permission of the ACR and the presenter. Any use of the program content, which includes but is not limited to oral presentations, audiovisual materials used by speakers and program handouts, without the written consent of the ACR is prohibited. This policy applies before, during and after the meeting. The ACR will enforce its intellectual property rights and penalize those who infringe upon it.

The names, insignias, logos and acronyms of the ACR, the ARHP and the ACR Research and Education Foundation are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the written permission of the College.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special supplement of Arthritis & Rheumatism. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until 4:30 PM Eastern Time on Saturday, October 26, 2013. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy.

Copyright law covers all annual meeting abstracts published by the American College of Rheumatology. All rights reserved. No abstracts may be reproduced in any form or by any means, except as permitted under section 107 and 108 of the 1976 United States Copyright Act, without the prior permission of the publisher.

For the purposes of this statement, the term "ACR Abstracts" refers to all annual meeting abstracts as published in Arthritis & Rheumatism and posted online, including the abstracts accepted for presentation during ARHP sessions and the late-breaking category.

For the purposes of this statement, the term "ACR Posters" refers to the accepted abstracts as presented during the annual meeting. All ACR Posters are the property of the ACR or the presenting author and cannot be reproduced or distributed without written permission from the ACR and the presenting author.

For the purposes of this statement, the term "reproduce" includes all forms of reproduction including, but not limited to, print, electronic and photographed formats.

For the purposes of this statement, the term "presenting author" refers to the author who is designated as the individual who will present the work during the ACR annual meeting, as identified through the abstract submission process.

Approval Process
Excerpts of ACR Abstracts or ACR Abstracts in their entirety may not be reproduced without the prior written permission of the publisher. Permission requests and other permission inquiries should be addressed to:

• Permissions Department
  c/o John Wiley & Sons, Inc.
  111 River Street
  Hoboken, NJ 07030
  Fax: (201) 748-6008
  Web site: www.wiley.com/go/permissions

Commercial entities seeking permission to reprint must obtain all materials from the author and/or publisher John Wiley & Sons, Inc. ACR cannot provide any materials.

Reproducing ACR Abstracts for Dissemination Prior to the Annual Meeting
Requests to reproduce abstracts for dissemination prior to the annual meeting will not be approved. Per the ACR embargo policy, academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract online. Permission to issue a press release does not require ACR approval. However, it must comply with the ACR Embargo Policy; violation of this policy may result in the abstract being withdrawn from the meeting or other measures deemed appropriate.

Reproducing ACR Abstracts and ACR Posters for Dissemination During the Annual Meeting
Following approval (see approval process), an exhibiting organization may:

• Disseminate copies of individual ACR Abstracts from its exhibit space. Booklets of abstracts (e.g., two or more) may not be produced.
• Disseminate information summaries (title/date/time/poster number) of ACR Abstracts from its exhibit space. Summaries may not reference company or product names. Requests for approval must be submitted in writing to abstractreprints@rheumatology.org.

Presenting authors may disseminate individual copies of their ACR Poster during their assigned poster presentation time. Dissemination must be limited to the area directly in front of their assigned poster space and may not interfere with other poster presentations.

Reproducing ACR Abstracts and ACR Posters for Dissemination After the Annual Meeting
Following approval (see approval process), the ACR permits ACR Abstracts to be reprinted and disseminated following the annual meeting.

ACR Abstracts
Booklets of abstracts (e.g., two or more) must include the following statement on the front of the booklet:
Abstracts reprinted from the ACR/ARHP Annual Meeting held - October 25 – 30, 2013. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by (insert name of supporting company).

Booklets cannot contain corporate or product logos or any advertisements.

ACR Posters
Following approval from the ACR and the presenting author, copies of the ACR Posters may be reproduced.

The organization requesting permission to reproduce an ACR Poster must provide the presenting author's written approval for review by the ACR. Requests to reproduce individual ACR Posters or booklets of Posters (e.g., two or more) must be submitted in writing to abstractreprints@rheumatology.org.

The following statement must be listed under each Poster reprint:
Poster reprinted from the ACR/ARHP Annual Meeting held - October 25 – 30, 2013. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by (insert name of supporting company).

Use of the ACR Disclosure Key
It is suggested when referencing disclosures in the reprints, that the ACR's disclosure key be added to provide adequate context for abstracts:

• None: Nothing to disclose
• 1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
• 2. Research grants
• 3. Employment (full or part-time)
• 4. Ownership or partnership
• 5. Consulting fees or other remuneration (payment)
• 6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
• 7. Receipt of royalties
• 8. Speakers' bureau
• 9. Other

Use of the ACR's Name
The names, insignias, logos and acronyms of the ACR, the ARHP and the ACR Research and Education Foundation are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the written permission of the ACR.

Use of the ACR Scientific Program Content
Information displayed or presented at all sessions during the annual meeting is the property of the ACR or the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced or distributed without the written permission of the ACR and the presenter. Any use of the program content, which includes but is not limited to oral presentations, audiovisual materials used by speakers and program handouts, without the written consent of the ACR is prohibited. This policy applies before, during and after the meeting. The ACR will enforce its intellectual property rights and penalize those who infringe upon it.

Credentialed media attend the annual meeting to cover stories for consumer, trade and other media outlets, and are easily identified by their black press ribbons. Media has access to all general sessions and limited access (at the discretion of speakers) to Meet the Professor and Workshop sessions. Media may use hand-held audio recorders and still cameras; moving video recording is also permitted with the permission of the presenter(s). The exception to this policy is that no photos or video are allowed in the Exhibit Hall. Press who would like general photos of the Exhibit Hall can obtain these after the meeting from the ACR. Attendees who have questions about the ACR's media policies should contact the ACR Public Relations department.

As a courtesy to our presenters, ACR policy does not permit photographs or recordings during educational sessions, including poster sessions. The only exception to this is for registered media, who should review their registration materials for more information.

Attendance at scientific sessions is on a first-come, first-served basis. Rooms that have reached the maximum capacity will be closed. Sessions closed due to overcrowding may be redirected to an overflow room or made available on SessionSelect within 24 hours following the session.